Law360, New York (January 25, 2010, 6:59 PM ET) -- A federal appeals court has handed a win to German pharmaceutical company Boehringer Ingelheim International GmbH, reversing a 2008 ruling that invalidated a patent related to the company's Parkinson's disease treatment Mirapex for obviousness-type double patenting.
The decision by the the U.S. Court of Appeals for the Federal Circuit on Monday said the lower court had incorrectly concluded that a safe harbor provision is inapplicable in this case, reversing the district court's judgment of invalidity and remanding the case for further proceedings.
In 2008, Judge Joseph...
Fed. Circ. Finds Boehringer's Mirapex Patent Valid
To view the full article, take a free trial now.
